Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cardiovascular risk factor(s) prevalence in Greek hypertensives. Effect of gender and age

Journal of Human Hypertension volume 26, pages 443–451 (2012)Cite this article

Abstract

The aim of this study was to determine cardiovascular (CV) risk factors (RFs) and target organ damage clustering in 21280 Greek hypertensives stratified by gender and age. Glycemic and lipid profile were determined, left ventricular mass index, estimated gromerular filtration rate (eGFR), 10-years CV risk according to Framingham risk score (FRS) and HeartScore (HS) were calculated. Only 10.2% of patients had no concomitant RFs, 53.1% had one (48.8% dyslipidemia, 3.4% smoking, 0.9% diabetes), 32.9% had two (26% dyslipidemia and smoking, 6.6% dyslipidemia and diabetes, 0.3% smoking and diabetes) and 3.7% had all four traditional RFs. Obesity was present in 30%, metabolic syndrome in 38%, low eGFR in 24% and left ventricular hypertrophy in 49%. Mean FRS risk was 35% for males, 24.1% for females whereas in high risk (>20%) were 68.7 and 50.7%, respectively (P<0.0001). Mean HS risk was 8.4% for males, 6.2% for females whereas in high risk (>5%) were 48.6 and 36.2%, respectively (P<0.0001). Age was correlated to pulse pressure, eGFR, left ventricular mass index and CV risk (P<0.0001). Ageing increased the risk difference between genders for total (P=0.001) but not for fatal events (P=nonsignificant). In conclusion, as RFs cluster in hypertensives, CV risk calculation should guide treatment decisions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Belletti DA, Zacker C, Wogen J . Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States. Cardiovasc Diabetol 2010; 9: 7–18.

    Article  Google Scholar 

  2. Kannel WB . Risk stratification in hypertension: new insights from the Framingham Study. Am J Hypertens 2000; 13: S3–S10.

    Article  Google Scholar 

  3. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM . Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006; 295: 1549–1555.

    Article  CAS  Google Scholar 

  4. Flegal KM, Graubard BI, Williamson DF, Gail MH . Excess deaths associated with underweight, overweight, and obesity. JAMA 2005; 293: 1861–1867.

    Article  CAS  Google Scholar 

  5. Giles T, Aranda JM, Suh DC, Choi IS, Preblick R, Rocha R et al. Ethnic/racial variations in blood pressure awareness, treatment, and control. J Clin Hypertens 2007; 9: 345–354.

    Article  Google Scholar 

  6. Ong KL, Tso AWK, Lam KSL, Cheung BMY . Gender differences in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension 2008; 51: 1142–1148.

    Article  CAS  Google Scholar 

  7. Sullivan PW, Ghushchyan V, Wyatt HR, Hill JO . The medical cost of cardiometabolic risk factor clusters in the United States. Obesity 2007; 15: 3150–3158.

    Article  Google Scholar 

  8. Farsang C, Naditch-Brule L, Perlini S, Zidek W, Kjeldsen SE . Inter-regional comparisons of the prevalence of cardiometabolic risk factors in patients with hypertension in Europe: the GOOD survey. J Hum Hypertens 2009; 23 (5): 316–324.

    Article  CAS  Google Scholar 

  9. Williams JR . The declaration of Helsinki and public health. Bull World Health Organ 2008; 86 (8): 650–652.

    Article  Google Scholar 

  10. Friedewald WT, Levy RI, Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

    CAS  Google Scholar 

  11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D . A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461–470.

    Article  CAS  Google Scholar 

  12. Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH . International federation of clinical chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of international reference material. Clin Chem 1994; 40: 586–592.

    CAS  PubMed  Google Scholar 

  13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Eur J Echocardiogr 2006; 7 (2): 79–108.

    Article  Google Scholar 

  14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206–1252.

    Article  CAS  Google Scholar 

  15. Mancia G, de Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–1187.

    Article  CAS  Google Scholar 

  16. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield M et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121–2158.

    Article  CAS  Google Scholar 

  17. The Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.

    Article  Google Scholar 

  18. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA et al. 2010 ACCF/AHA Guidelines for assessment of cardiovascular risk in asymptomatic adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2010; 56 (25): e50–e103.

    Article  Google Scholar 

  19. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM et al. General cardiovascular risk profile for use in primary care: the framingham heart study. Circulation 2008; 117: 743–753.

    Article  Google Scholar 

  20. Conroy RM, Pyörälä K, Fitzgerald A, Sans S, Menotti A, De Backer G et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.

    Article  CAS  Google Scholar 

  21. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2007; 28 (19): 2375–2414.

    Article  Google Scholar 

  22. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937–952.

    Article  Google Scholar 

  23. Pavlopoulos H, Nihoyannopoulos P . The constellation of hypertensive heart disease. Hellenic J Cardiol 2008; 49: 92–99.

    PubMed  Google Scholar 

  24. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D et al. European network for non-invasive investigation of large arteries: expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 21: 2588–2605.

    Article  Google Scholar 

  25. Ganotakis ES, Mikhailidis DP, Vardas PE . Atrial fibrillation, inflammation and statins. Hellenic J Cardiol 2006; 2: 51–53.

    Google Scholar 

  26. Konstantopoulou AS, Papargyriou IK, Antoniadou ES, Konstantopoulou PS, Papadogiannis DE . Masked hypertension: a new entity under investigation. Hellenic J Cardiol 2006; 4: 232–235.

    Google Scholar 

Download references

Acknowledgements

We have no sources of support (including federal and industry support) to declare.

Author information

Authors and Affiliations

  1. 1st Cardiology Clinic, Hypertension Unit, University of Athens Medical School, Hippokration Hospital, Athens, Greece

    G P Vyssoulis, C I Liakos, S-M G Kyvelou, V E Tzamou, A P Michaelides, A I Triantafyllou, P G Spanos & C I Stefanadis

  2. 1st Cardiology Clinic, Antihypertension Center, Onassis Cardiosurgery Center, Athens, Greece

    E A Karpanou

Authors
  1. G P Vyssoulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E A Karpanou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C I Liakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S-M G Kyvelou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V E Tzamou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A P Michaelides
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A I Triantafyllou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P G Spanos
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C I Stefanadis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C I Liakos.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vyssoulis, G., Karpanou, E., Liakos, C. et al. Cardiovascular risk factor(s) prevalence in Greek hypertensives. Effect of gender and age. J Hum Hypertens 26, 443–451 (2012). https://doi.org/10.1038/jhh.2011.55

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2011.55

Keywords

This article is cited by

Search

Advanced search

Quick links